Skip to content
Clinical Trials – home

Odense University Hospital

Verifiedinfo

Denmark Baagoees Alle 15, 5700 Odense, Denmark

  • 218 trials recruiting
  • Arteriosclerosis · Crohn's disease · Neoplasm malignant
  • Adults and children

About Specializations

Odense University Hospital in Odense, Denmark specialises in clinical trials of conditions such as Arteriosclerosis, Crohn's disease, Neoplasm malignant, Interstitial lung disease, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Tract Diseases

The Department of Respiratory Medicine leads research at Odense University Hospital. A key focus is bronchiectasis with chronic pseudomonas aeruginosa colonization. Current studies evaluate IV AZD0292 for safety and its impact on reducing moderate‑to‑severe pulmonary exacerbations.

  • Assessment of a novel intravenous therapy for chronic airway infection
  • Safety and tolerability profiling in affected patients
  • Measurement of exacerbation frequency as a primary outcome
  • Exploration of drug distribution and pharmacokinetics in the lung

With 186 investigators participating, the program advances targeted treatments for respiratory tract diseases across Europe.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Baagoees Alle 155700 OdenseDenmark
Recruiting now
218 trials
Conditions studied
221
Partner status
Verified

More sites in OdenseDenmark

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

493 clinical trials

Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Amgen Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:GSK3862995B
  • Sponsor:GSK PLC
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.

Migraine

Recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
  • Sponsor:Merz Therapeutics GmbH

Migraine

Recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
  • Sponsor:Merz Therapeutics GmbH
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB

Crohn's disease

Recruiting
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Daiichi Sankyo Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.